Ignite Creation Date:
2024-05-06 @ 1:33 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01837511
Status:
COMPLETED
Last Update Posted:
2013-04-23
First Post:
2013-04-05
Brief Title:
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I II and III Non-Small Cell Lung CancerNSCLC in Asiatic Patients
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
377
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 21399 |
Who Masked List: